Peptide receptor-targeted radionuclide therapy alters inflammation in atherosclerotic plaques

J Am Coll Cardiol. 2013 Dec 17;62(24):2344-5. doi: 10.1016/j.jacc.2013.08.1624. Epub 2013 Sep 25.

Authors

Imke Schatka¹, Tim Wollenweber¹, Cathleen Haense¹, Friederike Brunz¹, Klaus F Gratz¹, Frank M Bengel²

Affiliations

¹ Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany.
² Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany. Electronic address: bengel.frank@mh-hannover.de.

PMID: 24076295
DOI: 10.1016/j.jacc.2013.08.1624

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Female
Humans
Hypercholesterolemia / pathology
Inflammation / pathology
Inflammation / therapy*
Male
Middle Aged
Multimodal Imaging
Neuroendocrine Tumors / radiotherapy
Organometallic Compounds / therapeutic use
Plaque, Atherosclerotic / pathology*
Positron-Emission Tomography
Radiopharmaceuticals / therapeutic use
Radiotherapy / methods*
Receptors, Somatostatin / metabolism*
Retrospective Studies
Tomography, X-Ray Computed

Substances

Organometallic Compounds
Radiopharmaceuticals
Receptors, Somatostatin
SSTR2 protein, human
gallium Ga 68 dotatate